What Are Investors Betting On In Generative AI in Healthcare?
Audio is streamed directly from the publisher (podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Generative AI is definitely the word we will remember 2023 by. Knowing that administrative burden is among the key reason for physician burnout, the idea that AI could tackle this challenge, became a little bit more tangible with the raised awareness and public understanding of generative AI. But where are we exactly, and how is generative AI utilized for clinical use cases, administration, patient care and in biotech?
GSR Ventures and Maven Ventures are two health technology-focused VC firms that analyzed 145 startups across healthcare delivery and life sciences with generative AI solutions. They highlighted their innovations, challenges, and market potential. Collectively, the startups have earned more than $20 billion in funding and have 47,000 employees.
I had the pleasure to chat with Partner at GSR Ventures Justin Norden about the report and details such as: why has biotech raised the most so far, why not are startups working on the administrative issues, how do investors look at liability issues with generative AI, and what exactly are they looking for in startups, apart from a great team?
Full generative AI companies in healthcare report: https://aicheckup.substack.com/p/where-generative-ai-meets-healthcare
www.facesofdigitalhealth.com
Newsletter: fodh.substack.com
SPONSOR:
Magic Mind
Go to magicmind.com/digitalhealth
use the code DIGITALHEALTH20 to get a discount on your purchase